Mechanisms whereby GCs lead to dyslipidemia could be summarized as direct increase in production of HDL in the liver, impaired catabolism of LDL, increase in the activity of lipoprotein lipase and subsequent increase in LDL and HDL2 levels and finally indirect increase in LDL and VLDL levels due to increased plasma insulin (5). Here, INS is linked to metabolic syndrome.